A new study by researchers in the Finance Department of the College of Business at the University of Nevada, Reno finds bond ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Fort Wayne Metals, Vascotube, EUROFLEX, ADMEDES, and MeKo MedTech have formed a collective to for pure, consistent, ...

The investment outlook has been uncertain thanks to factors like tariffs and trade wars, inflation concerns, a dispute ...

Danish pharmaceutical giant Novo Nordisk has announced a new 800-million-yuan (approximately USD 111.9 million) investment to ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...

Drug services provider Medtide (3880.HK) is looking to raise HK$514 million (410 million yuan or $65.48 million) in a listing on the Hong Kong stock market, with plans to invest the proceeds into ...

According to Fox News, recent research shows that weight-loss surgery delivers more significant results than the popular Ozempic (semaglutide) treatment, with patients experiencing greater and more ...

A key milestone for the company was the acquisition of Catalent sites, which expands its global fill-and-finish capabilities and ensures a more robust supply chain for future market demand.

Novo Nordisk capital allocation priorities prioritize attractive investments into the company, including supply chain expansions and R&D, as well as consistent dividend payout.